Literature DB >> 31508968

Nanoparticle Size Influences Antigen Retention and Presentation in Lymph Node Follicles for Humoral Immunity.

Yi-Nan Zhang1,2, James Lazarovits1,2, Wilson Poon1,2, Ben Ouyang1,2,3, Luan N M Nguyen1,2, Benjamin R Kingston1,2, Warren C W Chan1,2,4,5,6.   

Abstract

Lymph node follicles capture and retain antigens to induce germinal centers and long-lived humoral immunity. However, control over antigen retention has been limited. Here we discovered that antigen conjugated to nanoparticle carriers of different sizes impacts the intralymph node transport and specific cell interaction. We found that follicular dendritic cell (FDC) networks determine the intralymph node follicle fate of these nanoparticles by clearing smaller ones (5-15 nm) within 48 h and retaining larger ones (50-100 nm) for over 5 weeks. The 50-100 nm-sized nanoparticles had 175-fold more delivery of antigen at the FDC dendrites, 5-fold enhanced humoral immune responses of germinal center B cell formation, and 5-fold more antigen-specific antibody production over 5-15 nm nanoparticles. Our results show that we can tune humoral immunity by simply manipulating the carrier size design to produce effectiveness of vaccines.

Keywords:  Nanoparticle; antigen retention and presentation; complement; follicular dendritic cells; germinal centers; lymph node

Mesh:

Substances:

Year:  2019        PMID: 31508968     DOI: 10.1021/acs.nanolett.9b02834

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  32 in total

1.  New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes.

Authors:  Mario Amacker; Charli Smardon; Laura Mason; Jack Sorrell; Kirk Jeffery; Michael Adler; Farien Bhoelan; Olga Belova; Mark Spengler; Beena Punnamoottil; Markus Schwaller; Olivia Bonduelle; Behazine Combadière; Toon Stegmann; Andrew Naylor; Richard Johnson; Desmond Wong; Sylvain Fleury
Journal:  NPJ Vaccines       Date:  2020-05-18       Impact factor: 7.344

2.  Rate of Immune Complex Cycling in Follicular Dendritic Cells Determines the Extent of Protecting Antigen Integrity and Availability to Germinal Center B Cells.

Authors:  Theinmozhi Arulraj; Sebastian C Binder; Michael Meyer-Hermann
Journal:  J Immunol       Date:  2021-02-19       Impact factor: 5.422

Review 3.  Innovations in lymph node targeting nanocarriers.

Authors:  Jihoon Kim; Paul A Archer; Susan N Thomas
Journal:  Semin Immunol       Date:  2021-11-24       Impact factor: 11.130

Review 4.  Cell and tissue engineering in lymph nodes for cancer immunotherapy.

Authors:  Alexander J Najibi; David J Mooney
Journal:  Adv Drug Deliv Rev       Date:  2020-08-01       Impact factor: 15.470

Review 5.  Shaping humoral immunity to vaccines through antigen-displaying nanoparticles.

Authors:  Darrell J Irvine; Benjamin J Read
Journal:  Curr Opin Immunol       Date:  2020-03-19       Impact factor: 7.486

6.  Quantitation of lymphatic transport mechanism and barrier influences on lymph node-resident leukocyte access to lymph-borne macromolecules and drug delivery systems.

Authors:  Paul A Archer; Lauren F Sestito; Margaret P Manspeaker; Meghan J O'Melia; Nathan A Rohner; Alex Schudel; Yajun Mei; Susan N Thomas
Journal:  Drug Deliv Transl Res       Date:  2021-06-24       Impact factor: 4.617

Review 7.  Protein-based antigen presentation platforms for nanoparticle vaccines.

Authors:  Brian Nguyen; Niraj H Tolia
Journal:  NPJ Vaccines       Date:  2021-05-13       Impact factor: 7.344

8.  Renal clearable nanocarriers: Overcoming the physiological barriers for precise drug delivery and clearance.

Authors:  Chuanqi Peng; Yingyu Huang; Jie Zheng
Journal:  J Control Release       Date:  2020-03-16       Impact factor: 9.776

Review 9.  Eliciting B cell immunity against infectious diseases using nanovaccines.

Authors:  Ankur Singh
Journal:  Nat Nanotechnol       Date:  2020-11-16       Impact factor: 39.213

10.  Combined PET and whole-tissue imaging of lymphatic-targeting vaccines in non-human primates.

Authors:  Jacob T Martin; Brittany L Hartwell; Sidath C Kumarapperuma; Mariane B Melo; Diane G Carnathan; Benjamin J Cossette; Josetta Adams; Siqi Gong; Wei Zhang; Talar Tokatlian; Sergey Menis; Torben Schiffner; Crystal G Franklin; Beth Goins; Peter T Fox; Guido Silvestri; William R Schief; Ruth M Ruprecht; Darrell J Irvine
Journal:  Biomaterials       Date:  2021-05-14       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.